Status:
UNKNOWN
Frailty Syndrome of Post-cancer Treatment Eldery Patients
Lead Sponsor:
University Hospital, Grenoble
Conditions:
Frailty Syndrome
Exercise
Eligibility:
All Genders
70+ years
Phase:
NA
Brief Summary
Decrease the prevalence of frailty syndrome in individuals with complete response of cancer.
Eligibility Criteria
Inclusion
- in complete remission from cancer (all type of cancer)
- have a frailty syndrome (positive GFST score)
- ability to provide signed informed consent
- be affiliated with social security or beneficiary of such a scheme
Exclusion
- patient with active cancer or any other pathology affecting the prognosis at 5 years
- currently participating or having participated in the month preceding inclusion in another interventional clinical research that may impact the study. This impact is left to the investigator discretion
- subjects referred to articles L1121-5 to L1121-8 of CSP (corresponds to all protected persons: person deprived of liberty by judicial or administrative decision, person subject to legal protection measure)
Key Trial Info
Start Date :
May 4 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04746768
Start Date
May 4 2021
End Date
January 1 2024
Last Update
June 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Grenoble
Grenoble, France